These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20639853)

  • 21. Short-term effect of amantadine sulphate on motor performance and reaction time in patients with idiopathic Parkinson's disease.
    Pinter MM; Birk M; Helscher RJ; Binder H
    J Neural Transm (Vienna); 1999; 106(7-8):711-24. PubMed ID: 10907729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cognitive dysfunction in patients with Parkinson's disease].
    Zakharov VV; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):13-9. PubMed ID: 15704477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical predictors of cognitive impairment and psychiatric complications in Parkinson's disease.
    Campos LS; Guimarães RP; Piovesana LG; Azevedo PC; Santos LM; D'Abreu A
    Arq Neuropsiquiatr; 2015 May; 73(5):390-5. PubMed ID: 26017203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amantadine improves gait in PD patients with STN stimulation.
    Chan HF; Kukkle PL; Merello M; Lim SY; Poon YY; Moro E
    Parkinsonism Relat Disord; 2013 Mar; 19(3):316-9. PubMed ID: 23218842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications.
    Solla P; Cannas A; Floris GL; Orofino G; Costantino E; Boi A; Serra C; Marrosu MG; Marrosu F
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1009-13. PubMed ID: 21324349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emotional and cognitive social processes are impaired in Parkinson's disease and are related to behavioral disorders.
    Narme P; Mouras H; Roussel M; Duru C; Krystkowiak P; Godefroy O
    Neuropsychology; 2013 Mar; 27(2):182-92. PubMed ID: 23527646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.
    Kulisevsky J; Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Campolongo A; García-Sánchez C; Pascual-Sedano B; Ribosa-Nogué R; Villa-Bonomo C
    Parkinsonism Relat Disord; 2013 Sep; 19(9):812-7. PubMed ID: 23773412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cognitive deterioration in Parkinson's disease].
    Perea-Bartolomé MV
    Rev Neurol; 2001 Jun 16-30; 32(12):1182-7. PubMed ID: 11562851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease.
    Bronnick K; Emre M; Tekin S; Haugen SB; Aarsland D
    Mov Disord; 2011 Apr; 26(5):824-9. PubMed ID: 21437985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Martínez-Corral M; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2010 Dec; 25(16):2785-91. PubMed ID: 20960483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Akatinol memantine in the therapy of cognitive disorders in Parkinson's disease].
    Puzin MN; Krivonos OV; Kozhevnikova ZhV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):26-9. PubMed ID: 17310793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson's disease.
    Růzicka E; Streitová H; Jech R; Kanovský P; Roth J; Rektorová I; Mecír P; Hortová H; Bares M; Hejduková B; Rektor I
    J Neural Transm (Vienna); 2000; 107(11):1297-306. PubMed ID: 11145005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
    Zangaglia R; Pacchetti C; Pasotti C; Mancini F; Servello D; Sinforiani E; Cristina S; Sassi M; Nappi G
    Mov Disord; 2009 Aug; 24(11):1621-8. PubMed ID: 19514093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cognition deterioration in Parkinson's disease: associated risk factors].
    Errea JM; Ara JR
    Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.
    Ory-Magne F; Corvol JC; Azulay JP; Bonnet AM; Brefel-Courbon C; Damier P; Dellapina E; Destée A; Durif F; Galitzky M; Lebouvier T; Meissner W; Thalamas C; Tison F; Salis A; Sommet A; Viallet F; Vidailhet M; Rascol O;
    Neurology; 2014 Jan; 82(4):300-7. PubMed ID: 24371304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and cognitive profiles of patients with both Parkinson's disease and essential tremor.
    Ozen Barut B; Gunal DI; Turkmen C; Mollahasanoğlu A; Ankaralı H
    Acta Neurol Belg; 2013 Jun; 113(2):117-25. PubMed ID: 22926528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.